Synthesis and in vivo characterization of D-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptors

Int J Rad Appl Instrum B. 1989;16(7):697-704. doi: 10.1016/0883-2897(89)90141-4.

Abstract

D-(+)-N1-Methyl-2-Br-LSD (MBL), which displays high affinity and selectivity for serotonin receptors in vitro, has been labeled with carbon-11 for localization of cerebral serotonin 5-HT2 receptors by positron emission tomography. [11C]MBL was prepared from [11C]iodomethane and D-(+)-2-Br-LSD within 20 min from end of bombardment. The average specific activity of [11C]MBL was 2300 mCi/mumol and the average radiochemical yield was 17%, both at end of synthesis. The in vivo regional distribution of radioactivity in brain after i.v. administration of [11C]MBL to mice paralleled the known density of serotonin 5-HT2 receptors. The maximum specific binding, defined by a frontal cortex to cerebellum radioactivity concentration ratio of 5.4 to 1, was reached 30 min postinjection. Administration of ketanserin, a potent serotonin 5-HT2 receptor antagonist, markedly blocked radioligand binding in all brain regions examined except cerebellum.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain / diagnostic imaging*
  • Carbon Radioisotopes
  • Isotope Labeling / methods*
  • Lysergic Acid Diethylamide / analogs & derivatives*
  • Male
  • Mice
  • Receptors, Serotonin / metabolism*
  • Tomography, Emission-Computed*

Substances

  • Carbon Radioisotopes
  • Receptors, Serotonin
  • N(1)-methyl-2-bromo-lysergic acid diethylamide
  • Lysergic Acid Diethylamide